Thermo Fisher Scientific

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:01 2024-04-22 pm EDT			5-day change	1st Jan Change
548.4 ^USD	+0.66%		-1.70%	+3.31%

Apr. 22	Bernstein Adjusts Price Target on Thermo Fisher Scientific to $544 From $520, Market Perform Rating Kept	MT
Apr. 22	Baird Adjusts Price Target on Thermo Fisher Scientific to $621 From $597	MT

Thermo Fisher Scientific Opens Manufacturing Site in Switzerland

October 01, 2021 at 04:41 am EDT

By Dave Sebastian

Thermo Fisher Scientific Inc. said it has opened a biologics manufacturing site in Lengnau, Switzerland, as part of its partnership with CSL Ltd.

The company on Friday said it would initially support the manufacturing of CSL's Idelvion drug for patients with hemophilia B after the construction for the 1.5 million-square-foot facility is completed in 2022. It would then serve more biopharma customers through the site.

Thermo Fisher said it would add about 200 employees in connection with the site.

The company's biologics manufacturing network currently includes Princeton, N.J.; St. Louis, Mo.; Groningen, Netherlands; Brisbane, Australia; and Hangzhou, China.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

10-01-21 0641ET

Latest news about Thermo Fisher Scientific

Bernstein Adjusts Price Target on Thermo Fisher Scientific to $544 From $520, Market Perform Rating Kept	Apr. 22	MT
Baird Adjusts Price Target on Thermo Fisher Scientific to $621 From $597	Apr. 22	MT
TD Cowen Raises Price Target on Thermo Fisher Scientific to $644 From $612	Apr. 17	MT
HSBC Adjusts Thermo Fisher Scientific Price Target to $660 From $630	Apr. 17	MT
Thermo Fisher Scientific Inc. Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing	Apr. 11	CI
Thermo Fisher Scientific Receives Shareholder Proposal from John Chevedden	Apr. 09	CI
Thermo Fisher Scientific Innovations at Analytica 2024 Optimize Workflows and Enable Precise Analysis Across Life Sciences, Applied and Industrial Markets	Apr. 09	CI
RBC Raises Price Target on Thermo Fisher Scientific to $657 From $642, Keeps Outperform Rating	Apr. 08	MT
Thermo Fisher Scientific Introduces Its Newest Line of High Performance, Ultra-Low Temperature Freezers	Apr. 08	CI
Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period	Apr. 04	MT
South Korean Trade Ministry, Thermo Fisher Scientific Explore Potential for Raw Biomaterials Facility	Mar. 28	MT
Thermo Fisher Scientific Announces A New In-Line Metrology Solution to Improve Battery Safety and Performance	Mar. 27	CI
Olink Swings to Q4 Net Loss, Revenue Rises	Mar. 25	MT
Bayer AG and Thermo Fisher Scientific Inc. Collaborate to Increase Patient Access to Precision Cancer Medicines	Mar. 20	CI
Thermo Fisher Scientific Insider Sold Shares Worth $5,945,759, According to a Recent SEC Filing	Mar. 14	MT
Thermo Fisher Scientific Insider Sold Shares Worth $11,933,356, According to a Recent SEC Filing	Mar. 13	MT
Thermo Fisher Scientific Insider Sold Shares Worth $8,591,221, According to a Recent SEC Filing	Mar. 13	MT
Thermo Fisher Scientific Inc. Launches Corevitas Clinical Registry in Generalized Pustular Psoriasis	Mar. 08	CI
Transcript : Thermo Fisher Scientific Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-06-2024 09:10 AM	Mar. 06
Thermo Fisher Scientific Insider Sold Shares Worth $5,710,818, According to a Recent SEC Filing	Mar. 04	MT
Thermo Fisher Scientific Extends Tender Offer Expiration for Olink Holding Shares	Mar. 01	MT
Thermo Fisher Scientific Insider Sold Shares Worth $11,348,955, According to a Recent SEC Filing	Feb. 29	MT
Agilent reports better-than-expected first quarter results, shares rise	Feb. 27	RE
LBT Innovations Delivers APAS Hardware, Software to Thermo Fisher	Feb. 23	MT
Thermo Fisher Scientific Raises Quarterly Dividend 11% to 39 Cents Per Share	Feb. 21	DJ

Chart Thermo Fisher Scientific

Duration

Period

More charts

Company Profile

Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-04-24 - Q1 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Thermo Fisher Scientific

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

548.4 USD

Average target price

610.3 USD

Spread / Average Target

+11.29%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+3.31%	209B
DANAHER CORPORATION	+2.05%	175B
INTUITIVE SURGICAL, INC.	+9.36%	131B
BOSTON SCIENTIFIC CORPORATION	+17.66%	99.98B
SIEMENS HEALTHINEERS AG	-1.10%	61.12B
EDWARDS LIFESCIENCES CORPORATION	+14.05%	52.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-4.15%	46.5B
AGILENT TECHNOLOGIES, INC.	-3.68%	39.24B
GE HEALTHCARE TECHNOLOGIES INC.	+9.04%	38.47B
RESMED, INC.	+4.84%	26.49B

Other Advanced Medical Equipment & Technology